News | RIVM

Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination

Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.

iGEM meetup for teams and supervisors

The best synbio projects, including iGEM teams, have one thing in common: cutting edge science in the light of carefully considered societal needs.

Blue spaces for all!

22 March UN World Water Day is all about attention on the importance of water.

Vaccination against meningococcal disease starts for teens aged 14 to 18

This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.

Vaccination schedule for babies reviewed after introduction whooping cough vaccination for pregnant women

Whooping cough is a dangerous disease for new born, unvaccinated babies. Starting at the end of 2019, the whooping cough vaccination will be offered nationwide to pregnant women.

Citizen Science Magazine; everyone's a scientist

“RIVM is committed to being innovative, and becoming a key player in citizen science is fully in line with that goal,” says Danielle Timmermans, Chief Science Officer for Risk Communication at RIVM

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Teen vaccination against meningococcal disease starts

From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.

Meningococcal type W most notable infectious disease in 2017

The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a

Large increase in legionellosis in the Netherlands

The Municipal Public Health Services (GGD) received 561 reports of legionellosis over the past year. Never before has RIVM registered as many reports of this disease as in the past year.